AGP Picks
View all

AI-driven AR surgical telementoring market seen reaching $5.88 billion by 2030

Jul. 25, 2026
By AI, Created 09:53 UTC, Jul 25, 2026, AGP -

The Business Research Company says the AI-driven augmented reality surgical telementoring market is set to grow from $2.2 billion in 2026 to $5.88 billion by 2030. The report points to labor shortages, telemedicine adoption, 5G rollout and rising demand for minimally invasive surgery as major growth drivers.

Why it matters: - AI-driven AR surgical telementoring is being positioned as a tool to improve surgical precision, remote collaboration and training. - The market’s projected jump to $5.88 billion by 2030 signals continued demand for technology that can extend specialist expertise beyond major medical centers. - Growth in the category could matter most for rural hospitals, training programs and complex procedures that need live guidance.

What happened: - The Business Research Company released a report on the global AI-driven augmented reality surgical telementoring market on July 25, 2026. - The report estimates the market will rise from $1.71 billion in 2025 to $2.2 billion in 2026. - The report forecasts the market will reach $5.88 billion by 2030. - The report describes a 28.2% CAGR for the 2025-2026 period and a 27.9% CAGR for the 2026-2030 forecast period. - North America held the largest market share in 2025.

The details: - The report links near-term growth to a shortage of skilled surgeons, wider telemedicine use, more demand for surgical training, improved connectivity and pilot telementoring projects. - The longer-term forecast is tied to 5G deployment, more AI-assisted surgeries, expanded global surgical education programs, better rural healthcare access and rising demand for complex procedures. - The report highlights expected trends including remote surgical collaboration, live surgical visualization, specialist access in remote locations, precision guidance during procedures and improved surgical training methods. - The technology combines AI and AR to provide real-time guidance during operations and more detailed visualization of anatomy and surgical steps. - The system is designed to support interactive cooperation, remote supervision and faster decision-making. - The report says the market’s appeal is supported by the broader shift toward minimally invasive surgery. - Minimally invasive procedures use small incisions and specialized tools to reduce pain, trauma and recovery time compared with open surgery. - The report cites a 5% rise in cosmetic surgical procedures in the UK from 2023 to 2024, reaching 27,462 surgeries in 2024. - The geographic scope also includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report package adds market attractiveness scoring, total addressable market analysis, a company scoring matrix, Excel-based forecasting dashboards, hotspot infographics, key technology and future-trend analysis, plus updated graphics and tables. - The report includes a free sample and the full market report at the sample report and the full report.

Between the lines: - The forecast suggests AI and AR are moving from niche surgical support tools toward broader clinical workflow infrastructure. - The emphasis on rural access and specialist reach points to a market story driven by care delivery gaps as much as by device innovation. - North America’s lead likely reflects a combination of health system spending, infrastructure and early adoption, while other regions remain growth opportunities.

What's next: - The report expects the market to keep expanding through 2030 as 5G, telemedicine and AI-assisted surgery become more embedded in care delivery. - Wider adoption of surgical education programs and remote mentoring could accelerate use cases beyond early pilots. - The next milestone for the market will be whether the technology scales from specialized centers into broader hospital networks.

The bottom line: - AI-driven AR surgical telementoring is emerging as a fast-growing market with clear clinical use cases, but its next phase depends on infrastructure, training and hospital adoption.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

UK Daily Ledger

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

UK Daily Ledger

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.